Huvitz Co. Ltd
Huvitz Co., Ltd. develops and sells optometric medical equipment worldwide. The company offers ophthalmic and optical equipment comprising refractive equipment, such as auto ref-keratometers, auto lensmeters, digital refractors, chart projectors, and unit tables; and diagnostic equipment comprising slit lamps, non-contact tonometers, and applanation tonometers, as well as ophthalmologic diagnosti… Read more
Huvitz Co. Ltd (065510) - Net Assets
Latest net assets as of September 2025: ₩121.35 Billion KRW
Based on the latest financial reports, Huvitz Co. Ltd (065510) has net assets worth ₩121.35 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩235.07 Billion) and total liabilities (₩113.72 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩121.35 Billion |
| % of Total Assets | 51.62% |
| Annual Growth Rate | 6.82% |
| 5-Year Change | 55.18% |
| 10-Year Change | 76.87% |
| Growth Volatility | 8.74 |
Huvitz Co. Ltd - Net Assets Trend (2011–2024)
This chart illustrates how Huvitz Co. Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Huvitz Co. Ltd (2011–2024)
The table below shows the annual net assets of Huvitz Co. Ltd from 2011 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩121.79 Billion | +10.14% |
| 2023-12-31 | ₩110.57 Billion | +7.34% |
| 2022-12-31 | ₩103.01 Billion | +17.11% |
| 2021-12-31 | ₩87.96 Billion | +12.07% |
| 2020-12-31 | ₩78.48 Billion | -10.79% |
| 2019-12-31 | ₩87.97 Billion | +4.85% |
| 2018-12-31 | ₩83.90 Billion | +6.64% |
| 2017-12-31 | ₩78.68 Billion | +1.86% |
| 2016-12-31 | ₩77.25 Billion | +12.19% |
| 2015-12-31 | ₩68.86 Billion | +5.72% |
| 2014-12-31 | ₩65.13 Billion | -0.26% |
| 2013-12-31 | ₩65.30 Billion | -0.02% |
| 2012-12-31 | ₩65.32 Billion | +26.40% |
| 2011-12-31 | ₩51.68 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Huvitz Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 44392.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩101.43 Billion | 87.77% |
| Common Stock | ₩6.08 Billion | 5.26% |
| Other Components | ₩8.06 Billion | 6.97% |
| Total Equity | ₩115.57 Billion | 100.00% |
Huvitz Co. Ltd Competitors by Market Cap
The table below lists competitors of Huvitz Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Agro Bahari Nusantara Tbk.
JK:UDNG
|
$43.64 Million |
|
Asian Alliance International PCL
BK:AAI
|
$43.65 Million |
|
Goodfellow Inc
PINK:GFELF
|
$43.65 Million |
|
RAUTE OY A EO 2
F:RAUA
|
$43.65 Million |
|
STAFFLINE GROUP LS-10
F:OSU
|
$43.62 Million |
|
ALTEA GREEN POWER S.P.A.
F:Q51
|
$43.60 Million |
|
Amogreentech Co.Ltd
KQ:125210
|
$43.58 Million |
|
Emc Gold Corporation
AU:EM3
|
$43.58 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Huvitz Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 110,571,048,620 to 115,567,337,070, a change of 4,996,288,450 (4.5%).
- Net income of 8,709,608,030 contributed positively to equity growth.
- Dividend payments of 2,170,979,000 reduced retained earnings.
- Share repurchases of 194,437,000 reduced equity.
- New share issuances of 194,437,000 increased equity.
- Other factors decreased equity by 1,542,340,580.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩8.71 Billion | +7.54% |
| Dividends Paid | ₩2.17 Billion | -1.88% |
| Share Repurchases | ₩194.44 Million | -0.17% |
| Share Issuances | ₩194.44 Million | +0.17% |
| Other Changes | ₩-1.54 Billion | -1.33% |
| Total Change | ₩- | 4.52% |
Book Value vs Market Value Analysis
This analysis compares Huvitz Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.82x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.30x to 0.82x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩6664.40 | ₩8680.00 | x |
| 2017-12-31 | ₩6787.26 | ₩8680.00 | x |
| 2018-12-31 | ₩7237.08 | ₩8680.00 | x |
| 2019-12-31 | ₩7723.44 | ₩8680.00 | x |
| 2020-12-31 | ₩7402.98 | ₩8680.00 | x |
| 2021-12-31 | ₩8296.65 | ₩8680.00 | x |
| 2022-12-31 | ₩9709.39 | ₩8680.00 | x |
| 2023-12-31 | ₩10186.28 | ₩8680.00 | x |
| 2024-12-31 | ₩10624.05 | ₩8680.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Huvitz Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.54%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.39%
- • Asset Turnover: 0.53x
- • Equity Multiplier: 1.92x
- Recent ROE (7.54%) is below the historical average (9.47%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 17.98% | 15.38% | 0.84x | 1.40x | ₩3.89 Billion |
| 2012 | 17.87% | 16.42% | 0.80x | 1.36x | ₩4.87 Billion |
| 2014 | 2.27% | 2.16% | 0.60x | 1.76x | ₩-4.69 Billion |
| 2015 | 9.49% | 9.38% | 0.61x | 1.66x | ₩-354.18 Million |
| 2016 | 14.33% | 16.54% | 0.48x | 1.81x | ₩3.34 Billion |
| 2017 | 3.95% | 4.42% | 0.50x | 1.79x | ₩-4.76 Billion |
| 2018 | 8.45% | 8.99% | 0.56x | 1.69x | ₩-1.30 Billion |
| 2019 | 8.95% | 8.95% | 0.58x | 1.73x | ₩-923.08 Million |
| 2020 | -3.47% | -3.89% | 0.45x | 1.98x | ₩-10.57 Billion |
| 2021 | 10.22% | 9.46% | 0.62x | 1.74x | ₩194.87 Million |
| 2022 | 16.58% | 15.60% | 0.62x | 1.72x | ₩6.77 Billion |
| 2023 | 9.02% | 8.47% | 0.59x | 1.82x | ₩-1.08 Billion |
| 2024 | 7.54% | 7.39% | 0.53x | 1.92x | ₩-2.85 Billion |
Industry Comparison
This section compares Huvitz Co. Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $103,504,524,391
- Average return on equity (ROE) among peers: 6.01%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Huvitz Co. Ltd (065510) | ₩121.35 Billion | 17.98% | 0.94x | $43.64 Million |
| Shinhung (004080) | $87.31 Billion | 3.50% | 0.52x | $10.80 Million |
| Osang Healthcare Co.,Ltd (036220) | $199.86 Billion | 20.34% | 0.25x | $37.44 Million |
| HansBiomed Corporation (042520) | $43.16 Billion | 11.38% | 0.21x | $246.58 Million |
| JVM Co. Ltd (054950) | $98.83 Billion | 10.23% | 0.72x | $117.37 Million |
| Vieworks Co. Ltd (100120) | $188.04 Billion | 17.80% | 0.28x | $101.54 Million |
| Corentec Co Ltd (104540) | $48.30 Billion | -3.04% | 0.46x | $40.80 Million |
| Hironic Co. Ltd (149980) | $40.72 Billion | 7.13% | 0.15x | $23.71 Million |
| Laseroptek Co., Ltd. (199550) | $-3.94 Billion | 0.00% | 0.00x | $21.68 Million |
| Humasis Co. Ltd (205470) | $229.26 Billion | -13.28% | 0.45x | $48.97 Million |